ACADIA Pharmaceuticals IncNASDAQ:ACAD
- LAST PRICE16.5300
- TODAY'S CHANGE (%)0.1100 (0.6699%)
- Bid / Lots15.5000/ 2
- Ask / Lots16.9000/ 1
- Open / Previous Close16.4100 / 16.4200
- Day Range
- 52 Week Range
- Volume1,526,042
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ACAD |
|---|---|---|
| 09:32 ET | 211320 | 16.33 |
| 09:34 ET | 1600 | 16.3 |
| 09:36 ET | 13750 | 16.205 |
| 09:38 ET | 898 | 16.19 |
| 09:39 ET | 1202 | 16.215 |
| 09:41 ET | 6300 | 16.21 |
| 09:43 ET | 387 | 16.27 |
| 09:45 ET | 854 | 16.28 |
| 09:50 ET | 1157 | 16.23 |
| 09:52 ET | 8620 | 16.22 |
| 09:54 ET | 13059 | 16.3 |
| 09:56 ET | 1190 | 16.2438 |
| 09:59 ET | 1707 | 16.345 |
| 10:01 ET | 9353 | 16.34 |
| 10:03 ET | 2747 | 16.36 |
| 10:06 ET | 2950 | 16.39 |
| 10:08 ET | 100 | 16.39 |
| 10:10 ET | 854 | 16.445 |
| 10:12 ET | 2760 | 16.43 |
| 10:14 ET | 300 | 16.44 |
| 10:15 ET | 1300 | 16.45 |
| 10:17 ET | 1040 | 16.46 |
| 10:19 ET | 635 | 16.5 |
| 10:21 ET | 900 | 16.51 |
| 10:24 ET | 800 | 16.51 |
| 10:26 ET | 303 | 16.52 |
| 10:28 ET | 2819 | 16.55 |
| 10:30 ET | 500 | 16.53 |
| 10:32 ET | 1229 | 16.51 |
| 10:33 ET | 150 | 16.5 |
| 10:35 ET | 2188 | 16.5 |
| 10:37 ET | 1200 | 16.44 |
| 10:39 ET | 1400 | 16.45 |
| 10:42 ET | 400 | 16.39 |
| 10:44 ET | 600 | 16.415 |
| 10:46 ET | 300 | 16.42 |
| 10:48 ET | 1633 | 16.43 |
| 10:50 ET | 1308 | 16.375 |
| 10:51 ET | 825 | 16.37 |
| 10:53 ET | 800 | 16.37 |
| 10:55 ET | 927 | 16.39 |
| 10:57 ET | 1174 | 16.4 |
| 11:00 ET | 1697 | 16.4 |
| 11:02 ET | 2095 | 16.44 |
| 11:04 ET | 2641 | 16.43 |
| 11:06 ET | 2937 | 16.435 |
| 11:08 ET | 435 | 16.445 |
| 11:09 ET | 800 | 16.43 |
| 11:11 ET | 566 | 16.41 |
| 11:13 ET | 200 | 16.41 |
| 11:15 ET | 1100 | 16.4 |
| 11:18 ET | 300 | 16.37 |
| 11:20 ET | 300 | 16.39 |
| 11:22 ET | 600 | 16.4 |
| 11:24 ET | 1600 | 16.385 |
| 11:26 ET | 500 | 16.39 |
| 11:27 ET | 300 | 16.41 |
| 11:29 ET | 1300 | 16.405 |
| 11:31 ET | 500 | 16.39 |
| 11:33 ET | 1600 | 16.36 |
| 11:36 ET | 1800 | 16.385 |
| 11:38 ET | 1284 | 16.435 |
| 11:40 ET | 10461 | 16.47 |
| 11:42 ET | 200 | 16.46 |
| 11:44 ET | 1417 | 16.46 |
| 11:45 ET | 100 | 16.45 |
| 11:47 ET | 1109 | 16.44 |
| 11:51 ET | 300 | 16.46 |
| 11:54 ET | 1500 | 16.44 |
| 11:58 ET | 200 | 16.45 |
| 12:00 ET | 2191 | 16.45 |
| 12:02 ET | 100 | 16.43 |
| 12:03 ET | 100 | 16.42 |
| 12:05 ET | 200 | 16.42 |
| 12:07 ET | 734 | 16.435 |
| 12:09 ET | 600 | 16.435 |
| 12:12 ET | 1003 | 16.43 |
| 12:14 ET | 200 | 16.43 |
| 12:16 ET | 1222 | 16.42 |
| 12:18 ET | 400 | 16.43 |
| 12:20 ET | 500 | 16.435 |
| 12:21 ET | 200 | 16.43 |
| 12:23 ET | 1335 | 16.45 |
| 12:25 ET | 1047 | 16.475 |
| 12:27 ET | 404 | 16.464 |
| 12:30 ET | 1742 | 16.44 |
| 12:32 ET | 100 | 16.45 |
| 12:34 ET | 100 | 16.45 |
| 12:36 ET | 700 | 16.44 |
| 12:38 ET | 300 | 16.43 |
| 12:39 ET | 200 | 16.435 |
| 12:41 ET | 400 | 16.445 |
| 12:43 ET | 300 | 16.445 |
| 12:45 ET | 599 | 16.45 |
| 12:48 ET | 1303 | 16.45 |
| 12:50 ET | 1183 | 16.45 |
| 12:52 ET | 200 | 16.46 |
| 12:54 ET | 1100 | 16.469 |
| 12:56 ET | 1324 | 16.46 |
| 12:57 ET | 1000 | 16.46 |
| 12:59 ET | 100 | 16.465 |
| 01:01 ET | 200 | 16.46 |
| 01:03 ET | 816 | 16.46 |
| 01:06 ET | 800 | 16.45 |
| 01:08 ET | 1700 | 16.46 |
| 01:10 ET | 1549 | 16.51 |
| 01:12 ET | 3217 | 16.49 |
| 01:14 ET | 700 | 16.48 |
| 01:15 ET | 912 | 16.5 |
| 01:17 ET | 300 | 16.5 |
| 01:19 ET | 4705 | 16.52 |
| 01:21 ET | 4800 | 16.52 |
| 01:24 ET | 5876 | 16.515 |
| 01:26 ET | 1850 | 16.54 |
| 01:28 ET | 2514 | 16.53 |
| 01:30 ET | 1500 | 16.54 |
| 01:32 ET | 1620 | 16.54 |
| 01:33 ET | 700 | 16.55 |
| 01:35 ET | 900 | 16.56 |
| 01:37 ET | 1900 | 16.555 |
| 01:39 ET | 300 | 16.555 |
| 01:42 ET | 1011 | 16.55 |
| 01:44 ET | 2200 | 16.545 |
| 01:46 ET | 1400 | 16.54 |
| 01:48 ET | 2000 | 16.52 |
| 01:50 ET | 230 | 16.525 |
| 01:51 ET | 900 | 16.5 |
| 01:53 ET | 400 | 16.51 |
| 01:55 ET | 2021 | 16.48 |
| 01:57 ET | 600 | 16.46 |
| 02:00 ET | 2177 | 16.47 |
| 02:02 ET | 2298 | 16.47 |
| 02:04 ET | 738 | 16.45 |
| 02:06 ET | 712 | 16.44 |
| 02:08 ET | 1320 | 16.44 |
| 02:09 ET | 301 | 16.45 |
| 02:11 ET | 2531 | 16.45 |
| 02:13 ET | 928 | 16.45 |
| 02:15 ET | 1786 | 16.45 |
| 02:18 ET | 900 | 16.445 |
| 02:20 ET | 200 | 16.45 |
| 02:22 ET | 2116 | 16.45 |
| 02:24 ET | 500 | 16.445 |
| 02:26 ET | 1400 | 16.45 |
| 02:27 ET | 800 | 16.46 |
| 02:29 ET | 2000 | 16.45 |
| 02:31 ET | 2222 | 16.44 |
| 02:33 ET | 1182 | 16.45 |
| 02:36 ET | 400 | 16.4581 |
| 02:38 ET | 1900 | 16.445 |
| 02:40 ET | 1662 | 16.465 |
| 02:42 ET | 4064 | 16.4526 |
| 02:44 ET | 1764 | 16.48 |
| 02:45 ET | 600 | 16.5 |
| 02:47 ET | 900 | 16.495 |
| 02:49 ET | 3101 | 16.52 |
| 02:51 ET | 500 | 16.52 |
| 02:54 ET | 1869 | 16.52 |
| 02:56 ET | 649 | 16.53 |
| 02:58 ET | 4102 | 16.542 |
| 03:00 ET | 3084 | 16.52 |
| 03:02 ET | 1947 | 16.52 |
| 03:03 ET | 500 | 16.52 |
| 03:05 ET | 2300 | 16.5 |
| 03:07 ET | 300 | 16.5 |
| 03:09 ET | 1885 | 16.49 |
| 03:12 ET | 4524 | 16.495 |
| 03:14 ET | 1327 | 16.5 |
| 03:16 ET | 300 | 16.495 |
| 03:18 ET | 3292 | 16.495 |
| 03:20 ET | 2414 | 16.505 |
| 03:21 ET | 2800 | 16.535 |
| 03:23 ET | 2710 | 16.545 |
| 03:25 ET | 2491 | 16.54 |
| 03:27 ET | 2900 | 16.545 |
| 03:30 ET | 485 | 16.55 |
| 03:32 ET | 4919 | 16.57 |
| 03:34 ET | 2800 | 16.54 |
| 03:36 ET | 3954 | 16.55 |
| 03:38 ET | 2203 | 16.535 |
| 03:39 ET | 4571 | 16.58 |
| 03:41 ET | 6148 | 16.555 |
| 03:43 ET | 1513 | 16.56 |
| 03:45 ET | 1900 | 16.57 |
| 03:48 ET | 5551 | 16.559 |
| 03:50 ET | 7097 | 16.545 |
| 03:52 ET | 4539 | 16.51 |
| 03:54 ET | 5726 | 16.505 |
| 03:56 ET | 22249 | 16.54 |
| 03:57 ET | 10277 | 16.49 |
| 03:59 ET | 617585 | 16.53 |
Aug 28, 2024
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences, from 4:05PM ET on Wednesday Aug 28, 2024 by Dow Jones
4:05PM ET on Wednesday Aug 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ACADIA Pharmaceuticals Inc | 2.7B | 91.2x | --- |
Azenta Inc | 2.4B | -17.5x | --- |
PTC Therapeutics Inc | 2.8B | -5.8x | --- |
Guardant Health Inc | 3.1B | -6.1x | --- |
Catalyst Pharmaceuticals Inc | 2.5B | 39.0x | --- |
Novavax Inc | 2.0B | -4.7x | --- |
Company Information
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Contact Information
- Headquarters
- 12830 El Camino Real, Suite 400SAN DIEGO, CA, United States 92130
- Phone
- 858-558-2871
- Fax
- 858-558-2872
Executives
- Independent Chairman of the Board
- Stephen Biggar
- Chief Executive Officer, Director
- Stephen Davis
- Chief Financial Officer, Executive Vice President
- Mark Schneyer
- Chief Operating Officer, Executive Vice President, Head of Commercial
- Brendan Teehan
- Executive Vice President, Company Secretary and Chief Legal Officer
- Jennifer Rhodes
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
|---|---|
Revenue (TTM) | $890.5M |
Shares Outstanding | 165.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.39 |
EPS | $0.18 |
Book Value | $2.62 |
P/E Ratio | 91.2x |
Price/Sales (TTM) | 3.1 |
Price/Cash Flow (TTM) | 64.8x |
Operating Margin | 2.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
